The client, Wyeth Pharmaceutical, was invoved in ensurring the aunch of its new vaccine against pneumococcal diseses, which the Government had incorporated into the childhood immunisation programme was fully supported.

Since this was the first new addition to the process since it was launched, it was important the educational process reach as many of the relevant medical professionals as possible.